header
    ABOUT | CONTACT | SUBSCRIBERSS    

Matthew Zubiller

Zubiller_Matt

Matthew Zubiller, Vice President, Strategy and Business Development, McKesson Matthew Zubiller drives strategy, operations, and product development for the McKesson Health Solutions business portfolio and specializes in innovative and disruptive technology strategies. He is a frequent speaker and author on topics such as next generation exception-based utilization management, innovation, decision support, and public policy for molecular and genetic testing.

Zubiller_Matt

Can Utilization Management Work in a Value-Based World?

August 5th, 2014

Beauty is in the eye of the beholder. And solutions to healthcare’s problems are in the eye of the stakeholder. Payers see the world one way, providers another, and patients still another. Finding...

Read More

Zubiller_Matt

Rethinking Traditional Utilization Management

September 5th, 2013

The September 2013 edition of Health Management Technology features an article by Matt Zubiller, vice president of Decision Management at McKesson Health Solutions. “Rethinking Traditional...

Read More

whcc

Actionable Strategies for Value-Based Healthcare Collaborative Decision Making

July 11th, 2013

Executive Insight covered this year’s annual meeting for America’s Health Insurance Plans (AHIP), where Matthew Zubiller, vice president of Decision Management at McKesson Health...

Read More

Zubiller_Matt

Code Mapping: Bringing Clarity to the CPT Conundrum

July 8th, 2013

A BIO-IT article examined the American Medical Association and McKesson agreement to map McKesson codes—Z-Code Identifiers to existing CPT codes.The AMA-McKesson agreement offers the first steps to...

Read More

government

Collaborative Decision Making: A Critical First Step to Achieving Value-Based Healthcare

July 1st, 2013

As healthcare reform continues to evolve, the shift toward a value-based system is underway amidst massive uncertainty. A clear path has not been established to ensure patients are receiving the...

Read More

ahip2013

AHIP’s Institute 2013: Clearing the way

May 17th, 2013

Clearing the way for healthcare reform and other pressing marketing demands isn’t easy. Healthcare organizations need to not only see the path forward but also begin the journey, confident that the...

Read More

lab_test

AMA/McKesson plans to help identify and track molecular diagnostic tests garner significant industry attention

March 27th, 2013

On February 26, the American Medical Association and McKesson jointly announced a “licensing relationship to offer the healthcare system a consistent and transparent way to identify and track...

Read More

caregiver

Content as a Service: Actionable Information at the Point of Care

March 4th, 2013

Matthew Zubiller, Laura Coughlin, RN, and A. Jacqueline Mitus, MD described the application of “content as a service” (CaaS) to healthcare on February 12 in Executive Insights:  With...

Read More

lab_test

A Truer Way To Measure Value of Diagnostic Tests

February 28th, 2013

In the Winter issue of Biotechnology Healthcare, Bob Carlson interviews Matthew Zubiller, vice president of Decision Management at McKesson Health Solutions, about the importance of helping payers...

Read More

lab_test

American Medical Association and McKesson team up to bring transparency to diagnostic testing

February 26th, 2013

Personalized medicine, specifically the use of molecular and genetic tests to diagnose patients, is a rapidly growing field. However, as the number of these tests increase, healthcare stakeholders...

Read More

McKesson    Twitter    LinkedIn    Email    Print

EMAIL NEWSLETTER